A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy

“Pomeroy, E. J., Hunzeker, J. T., Kluesner, M. G., Lahr, W. S., Smeester, B. A., Crosby, M. R., Lonetree, C., Yamamoto, K., Bendzick, L., Miller, J. S., Geller, M. A., Walcheck, B., Felices, M., Webber, B. R., Starr, T. K., Moriarity, B. S.  A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.  Molecular Therapy. 2020; 28(1), 52-63.  doi:10.1016/j.ymthe.2019.10.009